ClinicalTrialsFinder

Respiratory Synctial Virus Clinical Trials in Changchun

1 recruitingChangchun, China

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants

Respiratory Synctial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd.180 enrolled18 locationsNCT06775405